Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing - Contributions to Management Science - Gerrit Reepmeyer - Books - Springer-Verlag Berlin and Heidelberg Gm - 9783790816679 - December 5, 2005
In case cover and title do not match, the title is correct

Gerrit Reepmeyer
Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing - Contributions to Management Science 2006 edition

Price
$ 122.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Aug 5 - 17
Get notified about new Gerrit Reepmeyer releases

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously.

297 pages, 70 black & white illustrations, 10 black & white tables, biography

Media Books     Paperback Book   (Book with soft cover and glued back)
Released December 5, 2005
ISBN13 9783790816679
Publishers Springer-Verlag Berlin and Heidelberg Gm
Pages 297
Dimensions 155 × 235 × 16 mm   ·   439 g
Language English  

More from the same publisher

See all of Gerrit Reepmeyer ( e.g. Paperback Book )